Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ACXP
|
Carl Sailer
Director |
BUY
Open market or private purchase
|
Direct | 24,631 Added 15.22% |
$24,877
$1.01 p/Share
|
Jan 06
2025 |
|
WFRD
|
David John Reed
EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 4,762 Reduced 30.0% |
$346,006
$72.66 p/Share
|
Jan 06
2025 |
|
ABNB
|
Joseph Gebbia |
SELL
Open market or private sale
|
Indirect | 214,285 Reduced 0.0% |
$29,234,902
$136.43 p/Share
|
Jan 06
2025 |
|
ACXP
|
Joseph C Scodari
Director |
BUY
Open market or private purchase
|
Direct | 24,631 Added 47.06% |
$24,877
$1.01 p/Share
|
Jan 06
2025 |
|
ABNB
|
Elinor Mertz
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 6,250 Reduced 1.26% |
$856,250
$137.0 p/Share
|
Jan 06
2025 |
|
BRZE
|
Myles Kleeger
Pres & CCO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 5.14% |
$454,300
$45.43 p/Share
|
Jan 06
2025 |
|
BRZE
|
Susan Wiseman
General Counsel |
SELL
Open market or private sale
|
Direct | 14,000 Reduced 6.56% |
$641,340
$45.81 p/Share
|
Jan 06
2025 |
|
BRZE
|
Pankaj Malik
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 3,700 Reduced 6.33% |
$169,349
$45.77 p/Share
|
Jan 06
2025 |
|
FWBI
|
Sarah Romano
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 727 Reduced 4.04% |
$465
$0.64 p/Share
|
Jan 06
2025 |
|
CNX
|
Mfn Partners, LP |
SELL
Open market or private sale
|
Direct | 1,075,000 Reduced 7.17% |
$33,421,750
$31.09 p/Share
|
Jan 06
2025 |
|
ALXO
|
Shelly Pinto
SVP, FINANCE AND CAO |
SELL
Open market or private sale
|
Direct | 2,221 Reduced 2.46% |
$3,997
$1.8 p/Share
|
Jan 06
2025 |
|
CHWY
|
Sumit Singh
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 63,187 Reduced 8.94% |
$2,377,094
$37.62 p/Share
|
Jan 06
2025 |
|
LTBR
|
Larry Goldman
CFO |
SELL
Open market or private sale
|
Direct | 3,707 Reduced 1.84% |
$26,060
$7.03 p/Share
|
Jan 06
2025 |
|
BLUE
|
Andrew Obenshain
President and CEO |
SELL
Open market or private sale
|
Direct | 140 Reduced 0.75% |
$1,293
$9.24 p/Share
|
Jan 06
2025 |
|
BLUE
|
Richard A Colvin
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 19 Reduced 0.23% |
$175
$9.24 p/Share
|
Jan 06
2025 |
|
TW
|
Justin Peterson
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 6,669 Reduced 12.93% |
$882,842
$132.38 p/Share
|
Jan 06
2025 |
|
TW
|
Douglas Friedman
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 4,274 Reduced 12.68% |
$565,706
$132.36 p/Share
|
Jan 06
2025 |
|
TW
|
William Hult
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 15,163 Reduced 8.76% |
$2,007,277
$132.38 p/Share
|
Jan 06
2025 |
|
TW
|
Sara Furber
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 9,826 Reduced 13.01% |
$1,300,864
$132.39 p/Share
|
Jan 06
2025 |
|
TW
|
Scott Zucker
Chief Risk Officer |
SELL
Open market or private sale
|
Direct | 3,654 Reduced 13.68% |
$483,716
$132.38 p/Share
|
Jan 06
2025 |
|
CBIO
|
Songjiang Ma
President |
SELL
Open market or private sale
|
Indirect | 941 Reduced 0.0% |
$9,560
$10.16 p/Share
|
Jan 06
2025 |
|
CLS
|
Michael Wilson |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 93.34% |
$2,468,250
$98.73 p/Share
|
Jan 06
2025 |
|
APLS
|
Caroline Baumal
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 2,816 Reduced 4.82% |
$95,208
$33.81 p/Share
|
Jan 06
2025 |
|
DBX
|
Andrew Houston
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 29,917 Reduced 0.0% |
$899,604
$30.07 p/Share
|
Jan 06
2025 |
|
PCYG
|
Randall K Fields
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 2,500 Reduced 0.0% |
$55,450
$22.18 p/Share
|
Jan 06
2025 |
|
CET
|
John C Hill
CEO & President |
BUY
Open market or private purchase
|
Direct | 700 Added 0.95% |
$32,109
$45.87 p/Share
|
Jan 06
2025 |
|
CET
|
Andrew J O'Neill
Vice President |
BUY
Open market or private purchase
|
Direct | 1,309 Added 1.46% |
$59,755
$45.65 p/Share
|
Jan 06
2025 |
|
HMN
|
Beverley J. Mc Clure |
SELL
Open market or private sale
|
Direct | 2,817 Reduced 14.7% |
$108,060
$38.36 p/Share
|
Jan 06
2025 |
|
GLSI
|
Snehal Patel
CEO and CFO |
BUY
Open market or private purchase
|
Direct | 1,100 Added 0.02% |
$14,641
$13.31 p/Share
|
Jan 06
2025 |
|
KTOS
|
Stacey G Rock
President, KTT Division |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 6.53% |
$115,840
$28.96 p/Share
|
Jan 06
2025 |
|
ARWR
|
Kenneth Allen Myszkowski
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 27,167 Reduced 5.43% |
$540,351
$19.89 p/Share
|
Jan 06
2025 |
|
ARWR
|
Patrick O'Brien
COO and General Counsel |
SELL
Open market or private sale
|
Direct | 29,184 Reduced 5.17% |
$580,761
$19.9 p/Share
|
Jan 06
2025 |
|
ARWR
|
James C Hamilton
Chief Discovery/Trans Medicine |
SELL
Open market or private sale
|
Direct | 32,729 Reduced 10.74% |
$651,307
$19.9 p/Share
|
Jan 06
2025 |
|
WDAY
|
Carl M. Eschenbach
CEO |
SELL
Open market or private sale
|
Indirect | 6,250 Reduced 0.0% |
$1,593,500
$254.96 p/Share
|
Jan 06
2025 |
|
LPSN
|
Monica L. Greenberg
EVP, Policy & General Counsel |
SELL
Open market or private sale
|
Direct | 12,904 Reduced 2.22% |
$20,388
$1.58 p/Share
|
Jan 06
2025 |
|
RH
|
Keith Belling |
SELL
Open market or private sale
|
Direct | 500 Reduced 9.14% |
$208,925
$417.85 p/Share
|
Jan 06
2025 |
|
RH
|
Eri Chaya |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 100.0% |
$4,165,000
$416.5 p/Share
|
Jan 06
2025 |
|
W
|
Fiona Tan
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 7,581 Reduced 7.85% |
$357,974
$47.22 p/Share
|
Jan 06
2025 |
|
W
|
Kate Gulliver
CFO and Chief Admin Officer |
SELL
Open market or private sale
|
Direct | 5,754 Reduced 4.43% |
$271,416
$47.17 p/Share
|
Jan 06
2025 |
|
W
|
Jon Blotner
Pres., Commercial & Operations |
SELL
Open market or private sale
|
Direct | 4,521 Reduced 6.64% |
$212,758
$47.06 p/Share
|
Jan 06
2025 |
|
KALA
|
Mary Reumuth
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,706 Reduced 2.43% |
$13,016
$7.63 p/Share
|
Jan 06
2025 |
|
KALA
|
Mark T Iwicki
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 5,779 Reduced 2.02% |
$44,093
$7.63 p/Share
|
Jan 06
2025 |
|
KALA
|
Romulus K Brazzell |
SELL
Open market or private sale
|
Direct | 2,446 Reduced 2.58% |
$18,662
$7.63 p/Share
|
Jan 06
2025 |
|
KALA
|
Todd Bazemore |
SELL
Open market or private sale
|
Direct | 1,993 Reduced 2.14% |
$15,206
$7.63 p/Share
|
Jan 06
2025 |
|
KALA
|
Darius Kharabi
CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct | 2,021 Reduced 2.89% |
$15,420
$7.63 p/Share
|
Jan 06
2025 |
|
SELB
|
Blaine Davis
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 4,028 Reduced 4.08% |
$67,791
$16.83 p/Share
|
Jan 06
2025 |
|
SELB
|
Carsten Brunn
President and CEO |
SELL
Open market or private sale
|
Direct | 8,708 Reduced 4.09% |
$146,555
$16.83 p/Share
|
Jan 06
2025 |
|
SELB
|
Emily English
Chief Operations Officer |
SELL
Open market or private sale
|
Direct | 906 Reduced 2.2% |
$15,247
$16.83 p/Share
|
Jan 06
2025 |
|
SELB
|
Christopher M Jewell
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 1,286 Reduced 2.35% |
$21,643
$16.83 p/Share
|
Jan 06
2025 |
|
SELB
|
Milos Miljkovic
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 948 Reduced 2.61% |
$15,954
$16.83 p/Share
|
Jan 06
2025 |